Richmond L - Search Results

1

BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors.

Copland M, Pellicano F, Richmond L, Allan EK, Hamilton A, Lee FY, Weinmann R, Holyoake TL. Copland M, et al. Among authors: richmond l. Blood. 2008 Mar 1;111(5):2843-53. doi: 10.1182/blood-2007-09-112573. Epub 2007 Dec 21. Blood. 2008. PMID: 18156496 Free article.

2

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro.

Graham SM, Jørgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L, Holyoake TL. Graham SM, et al. Among authors: richmond l. Blood. 2002 Jan 1;99(1):319-25. doi: 10.1182/blood.v99.1.319. Blood. 2002. PMID: 11756187 Free article.

3

Enhanced CML stem cell elimination in vitro by bryostatin priming with imatinib mesylate.

Jørgensen HG, Allan EK, Mountford JC, Richmond L, Harrison S, Elliott MA, Holyoake TL. Jørgensen HG, et al. Among authors: richmond l. Exp Hematol. 2005 Oct;33(10):1140-6. doi: 10.1016/j.exphem.2005.05.020. Exp Hematol. 2005. PMID: 16219536 Free article.

4

Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro.

Jørgensen HG, Allan EK, Graham SM, Godden JL, Richmond L, Elliott MA, Mountford JC, Eaves CJ, Holyoake TL. Jørgensen HG, et al. Among authors: richmond l. Leukemia. 2005 Jul;19(7):1184-91. doi: 10.1038/sj.leu.2403785. Leukemia. 2005. PMID: 15889158

5

Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.

Holyoake TL, Freshney MG, Sproul AM, Richmond LJ, Alcorn MJ, Steward WP, Fitzsimons E, Dunlop DJ, Franklin IM, Pragnell IB. Holyoake TL, et al. Among authors: richmond lj. Stem Cells. 1993 Oct;11 Suppl 3:122-8. doi: 10.1002/stem.5530110925. Stem Cells. 1993. PMID: 8298472

6

CML leukapheresis products can be enriched for CD34+ cells and simultaneously depleted of CD15+ cells using a simple Ab cocktail.

Richmond LJ, Alcorn MJ, Pearson C, Cameron G, Thomas T, Eaves CJ, Eaves AC, Holyoake TL. Richmond LJ, et al. Cytotherapy. 2002;4(5):407-13. doi: 10.1080/146532402320775991. Cytotherapy. 2002. PMID: 12473207

7

CD34+ cells can be selected efficiently from cryopreserved peripheral blood progenitor cells and can retain their proliferative potential.

Alcorn MJ, Holyoake TL, Richmond LJ, Pearson C, Farrell E, Green R, Dunlop DJ, Franklin IM. Alcorn MJ, et al. Among authors: richmond lj. J Hematother. 1997 Oct;6(5):501-10. doi: 10.1089/scd.1.1997.6.501. J Hematother. 1997. PMID: 9368187

8

CD34 Selection and EX Vivo Expansion of Haemopoietic Progenitor Cells: A Review of Laboratory Methodology.

Holyoake TL, Alcorn MJ, Richmond LJ. Holyoake TL, et al. Among authors: richmond lj. Hematology. 1997;2(4):261-80. doi: 10.1080/10245332.1997.11746346. Hematology. 1997. PMID: 27405230

9

Stage-specific alterations in serum levels of G-CSF in chronic myeloid leukaemia.

Jørgensen HG, Allan EK, Jiang X, Liakopoulou E, Richmond L, Eaves CJ, Eaves AC, Holyoake TL. Jørgensen HG, et al. Among authors: richmond l. Leukemia. 2003 Jul;17(7):1430-2. doi: 10.1038/sj.leu.2402967. Leukemia. 2003. PMID: 12835742 No abstract available.

10

Efficient isolation of human CD34 positive hemopoietic progenitor cells by immune panninga.

Holyoake TL, Alcorn MJ, Richmond LJ, Freshney MG, Pearson C, Fitzsimons E, Steward WP, Dunlop DJ, Pragnell IB. Holyoake TL, et al. Among authors: richmond lj. Stem Cells. 1994 Jan;12(1):114-24. doi: 10.1002/stem.5530120118. Stem Cells. 1994. PMID: 7511456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters